Showing results (741-750 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|May 13, 2022
Hydroxychloroquine Blood Concentrations Can Be Clinically Relevant Also After Drug DiscontinuationSimona De Gregori, Francesco Falaschi, Alessia Ballesio, et al.Drugs in R&D|July 20, 2021
A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux SuppressionJeanine Fisher, Fiona McLaughlin, Neil Fawkes, et al.Drugs in R&D|August 5, 2017
Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and ValbenazineHeather Skor, Evan B Smith, Gordon Loewen, et al.Drugs in R&D|April 21, 2023
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical EvaluationAndré B P van Kuilenburg, Carla E M Hollak, Ana Travella, et al.Drugs in R&D|October 31, 2003
Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to ratsJost Leuschner, Jens Opitz, Andreas Winkler, et al.Drugs in R&D|October 31, 2003
Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administrationRisto Huupponen, Outi Paija, Markku Salonen, et al.Drugs in R&D|October 31, 2003
Cinacalcet: AMG 073, Calcimimetics--Amgen/NPS Pharmaceuticals, KRN 1493, NPS 1493Drugs in R&D|October 31, 2003
Doripenem: S 4661Drugs in R&D|October 31, 2003
Petasites--Zeller: ZE 339Drugs in R&D|May 22, 2003
Effects of levocarnitine on mitochondrial antioxidant systems and oxidative stress in aged ratsSundaram Kumaran, Balasubramanium Deepak, Balasubramanium Naveen, et al.Pageof 89